Hemodynamic changes in standing-up test of children and adolescents with postural tachycardia syndrome

  • Chun-yan TAO ,
  • Hong-xia LI ,
  • Xue-ying LI ,
  • Chao-shu TANG ,
  • Hong-fang JIN ,
  • Jun-bao DU
Expand
  • 1. Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
    2. Department of Statistics, Peking University First Hospital, Beijing 100034, China
    3. Department of Physiology and Pathophysiology, Peking University School of Basic Medical Sciences, Beijing 100191, China
    4. Key Laboratory of Molecular Cardiovascular Science, the Ministry of Education, Beijing 100191, China

Received date: 2019-03-12

  Online published: 2019-06-26

Supported by

Supported by the fundamental Research Funds for the Central Universities: Peking University Clinical Scientist Program (BMU2019LCKXJ001)

Abstract

Objective: To explore the hemodynamic changes in standing-up test of children and adolescents with postural tachycardia syndrome (POTS) and to compare hemodynamic parameters of POTS patients with decreased cardiac index (CI) and those with not-decreased CI.Methods: A retrospective study was conducted to show the trends of CI, total peripheral vascular resistance index (TPVRI), heart rate and blood pressure in standing-up test of 26 POTS patients and 12 healthy controls, and to compare them between the two groups. The POTS patients were divided into two groups based on CI decreasing or not in standing-up test, namely decreased CI group (14 cases) and not-decreased CI group (12 cases). The trends of the above mentioned hemodynamic parameters in standing-up test were observed and compared between decreased CI group and not-decreased CI group.Results: In standing-up test for all the POTS patients, CI (F=6.936, P=0.001) and systolic blood pressure (F=6.049, P<0.001) both decreased significantly, and heart rate increased obviously (F=113.926, P<0.001). However, TPVRI (F=2.031, P=0.138) and diastolic blood pressure (F=2.018, P=0.113) had no significant changes. For healthy controls, CI (F=3.646, P=0.016), heart rate (F=43.970, P<0.001), systolic blood pressure (F=4.043, P=0.020) and diastolic blood pressure (F=8.627, P<0.001) all increased significantly in standing-up test. TPVRI (F=1.688, P=0.190) did not change obviously. The changing trends of CI (F=6.221, P=0.001), heart rate (F=6.203, P<0.001) and systolic blood pressure (F=7.946, P<0.001) over time were significantly different between the patients and healthy controls, however, no difference was found in TPVRI and diastolic blood pressure (P > 0.05). Among the POTS patients, CI was significantly different between decreased CI group and not-decreased CI group (F=14.723, P<0.001). Systolic blood pressure of the former decreased obviously (F=8.010, P<0.001), but it did not change obviously in the latter (F=0.612, P=0.639). Furthermore, none of the changes of TPVRI, heart rate and diastolic blood pressure in standing-up test were significantly different between the two groups (P > 0.05). Age was an independent factor for decreased CI patients (P=0.013, OR=2.233; 95% CI, 1.183 to 4.216).Conclusion: POTS patients experience vital hemodynamic changes in standing-up test, part of them suffering from decreased CI, but others from not-decreased CI. Age is an independent factor for patients suffering from decreased CI.

Cite this article

Chun-yan TAO , Hong-xia LI , Xue-ying LI , Chao-shu TANG , Hong-fang JIN , Jun-bao DU . Hemodynamic changes in standing-up test of children and adolescents with postural tachycardia syndrome[J]. Journal of Peking University(Health Sciences), 2019 , 51(3) : 414 -421 . DOI: 10.19723/j.issn.1671-167X.2019.03.007

References

[1] Goodman BP . Evaluation of postural tachycardia syndrome (POTS)[J]. Auton Neurosci, 2018,215:12-19.
[2] Johnson JN, Mack KJ, Kuntz NL , et al. Postural orthostatic tachycardia syndrome: a clinical review[J]. Pediatr Neurol, 2010,42(2):77-85.
[3] Stewart JM, Pianosi P, Shaban MA , et al. Postural hyperventilation as a cause of postural tachycardia syndrome: increased systemic vascular resistance and decreased cardiac output when upright in all postural tachycardia syndrome variants[J]. J Am Heart Assoc, 2018,7(13):e008854.
[4] Li H, Han Z, Chen S, et al. Total peripheral vascular resistance, cardiac output ,plasma C-type natriuretic peptide level in children with postural tachycardia syndrome[J]. J Pediatr, 2015, 166(6): 1385- 1389. e1-2.
[5] Zheng X, Chen Y, Du J . Recent advances in the understanding of the mechanisms underlying postural tachycardia syndrome in children: practical implications for treatment[J]. Cardiol Young, 2017,27(3):413-417.
[6] Medow MS, Stewart JM . The postural tachycardia syndrome[J]. Cardiol Rev, 2007,15(2):67-75.
[7] 中华医学会儿科学分会心血管学组, 《中华儿科杂志》编辑委员会, 北京医学会儿科学分会心血管学组, 等. 2016儿童晕厥诊断指南(2016年修订版)[J]. 中华儿科杂志, 2016,54(4):246-250.
[8] 中华医学会儿科学分会心血管学组, 《中华儿科杂志》编辑委员会. 儿童晕厥诊断指南[J]. 中华儿科杂志, 2009,47(2):99-101.
[9] Garland EM, Celedonio JE, Raj SR . Postural tachycardia syndrome: beyond orthostatic intolerance[J]. Curr Neurol Neurosci Rep, 2015,15(9):60.
[10] Stewart JM, Medow MS, Glover JL , et al. Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome[J]. Am J Physiol Heart Circ Physiol, 2006,290(2):H665-H673.
[11] Fu Q, Vangundy TB, Galbreath MM , et al. Cardiac origins of the postural orthostatic tachycardia syndrome[J]. J Am Coll Cardiol, 2010,55(25):2858-2868.
[12] Jacob G, Biaggioni I, Mosqueda-Garcia R , et al. Relation of blood volume and blood pressure in orthostatic intolerance[J]. Am J Med Sci, 1998,315(2):95-100.
[13] Farquhar WB, Taylor JA, Darling SE , et al. Abnormal baroreflex responses in patients with idiopathic orthostatic intolerance[J]. Circulation, 2000,102(25):3086-3091.
[14] Zhang Q, Liao Y, Tang C , et al. Twenty-four-hour urinary sodium excretion and postural orthostatic tachycardia syndrome[J]. J Pediatr, 2012,161(2):281-284.
[15] 蔺婧, 刘平, 王瑜丽 , 等. 儿童体位性心动过速综合征治疗随访的单中心研究[J]. 中华实用儿科临床杂志, 2015,30(13):983-987.
[16] 蔺婧, 刘平, 王瑜丽 , 等. 直立试验心率变化预测口服补液盐治疗体位性心动过速综合征的效果[J]. 中华儿科杂志, 2015,53(1):25-29.
[17] Li H, Wang Y, Liu P , et al. Body mass index (BMI) is associated with the therapeutic response to oral rehydration solution in children with postural tachycardia syndrome[J]. Pediatr Cardiol, 2016,37(7):1313-1318.
[18] Lu W, Yan H, Wu S , et al. Hemocytometric measures predict the efficacy of oral rehydration for children with postural tachycardia syndrome[J]. J Pediatr, 2017,187:220-224.
[19] Raj SR, Robertson D . Blood volume perturbations in the postural tachycardia syndrome[J]. Am J Med Sci, 2007,334(1):57-60.
[20] Karata? Z, Alp H, Sap F , et al. Usability of QTc dispersion for the prediction of orthostatic intolerance syndromes[J]. Eur J Paediatr Neurol, 2012,16(5):467-474.
[21] Wang Y, Zhang C, Chen S , et al. Frequency domain indices of heart rate variability are useful for differentiating vasovagal syncope and postural tachycardia syndrome in children[J]. J Pediatr, 2019,207:59-63.
[22] Lin J, Jin H, Du J . Assessment of therapeutic biomarkers in the treatment of children with postural tachycardia syndrome and vasovagal syncope[J]. Cardiol Young, 2014,24(5):792-796.
[23] Altun B, Arici M . Salt and blood pressure: time to challenge[J]. Cardiology, 2006,105(1):9-16.
[24] Hart EC, Joyner MJ, Wallin BG , et al. Sex, ageing and resting blood pressure: gaining insights from the integrated balance of neural and haemodynamic factors[J]. J Physiol, 2012,590(9):2069-2079.
[25] Bevan JA . Control of peripheral vascular resistance: evidence based on the in vitro study of resistance arteries[J]. Clin Invest Med, 1987,10(6):568-572.
Outlines

/